(Press-News.org) Researchers from the University of Liverpool have found that approximately half of patients who have an eye removed because of a form of eye cancer experience `phantom eye syndrome.'
Patients with the condition experience "seeing" and pain in the eye that is no longer there. Researchers assessed 179 patients whose eye had been removed as a result of a cancer, called intraocular melanoma.
They found that more than a third of the patients experienced phantom eye symptoms every day. In most patients, the symptoms ceased spontaneously, but some patients reported that they have to do something to stop the sensation, such as distracting themselves or blinking.
The 'phantom' sensations often start several weeks after the eye is removed, eventually subsiding over time. Most see only patterns or colours, but some feel they see people and scenes.
More than one-in-four reported that they sometimes feel that they can even see what is actually happening around them. A similar number feel pain in the non-existent eye.
The researchers found that a fifth of patients find these sensations pleasurable, but a similar number are disturbed by them.
Health psychologist Laura Hope-Stone, from the University's Institute of Psychology, Health and Society (IPHS) who led the research, said: "To our knowledge, this is the largest study of phantom symptoms in patients who have lost an eye for intraocular melanoma.
"We carried out the study because many patients have told me about symptoms like this when I see them after surgery for psychological support, but we did not know exactly how common they are."
Health psychologist, Dr Steve Brown, also from IPHS, added: "The size of the study means we can now tell whether certain kinds of people are more likely to have phantom symptoms.
"They are most common in younger patients, and having pain in the non-existent eye is more likely in patients who are anxious or depressed, although we don't yet know why that's the case."
Professor Heinrich Heimann, who leads the Liverpool Ocular Oncology Centre at the Royal Liverpool University Hospital where the study was conducted, and the largest of the four UK centres which treat ocular melanoma, said: "These results are important because now we can tell patients not to be alarmed if they experience visual sensations or pain afterwards.
"We can also warn them that, unfortunately, removing an eye does not guarantee that there will be no pain weeks or months afterwards."
INFORMATION:
The study is part of the Liverpool Psychology in Cancer Care Research Group's programme of research into psychological and emotional aspects of the experience of cancer and treatment. The group is part of the Psychology of Healthcare Research Group in the Institute of Psychology, Health and Society.
The research is published in Ophthalmology: http://dx.doi.org/10.1016/j.ophtha.2015.04.005
Understanding the volcanic activity on Earth is not only important in order to limit the impact of natural disasters, volcanic eruptions also have a large impact on the climate and evolution of life on our planet. However, many details in the history of volcanic activity are still unknown. Scientists from the GEOMAR Helmholtz Centre for Ocean Research Kiel, together with colleagues from the USA, Taiwan, Australia and Switzerland, now have been able to track the development of the Galapagos volcanoes in the time frame between eight and 16 million years ago. In the process ...
Insulin degludec (trade name: Tresiba) has been approved since January 2015 for adolescents and children from the age of one year with type 1 or type 2 diabetes mellitus. In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal Products (AMNOG), the German Institute for Quality and Efficiency in Health Care (IQWiG) has now examined whether this new drug, alone or in combination with other blood-glucose lowering drugs, offers an added benefit over the appropriate comparator therapy.
No added benefit of insulin degludec for adolescents ...
The effort to identify new ways of fighting infections has taken a step forward now that scientists have identified a key protein involved in the host's response to strep infections. This protein, called "NFAT," appears to play a key role in the body's inflammatory response to an infection, which when uncontrolled, can be as bad, if not worse, than the infection itself. Furthermore, this discovery was made using streptococcal bacteria, which are responsible for a wide range of human illnesses, ranging from sore throat and pink eye to meningitis and bacterial pneumonia. ...
CAMBRIDGE, Mass--Most of the world's electricity-producing power plants -- whether powered by coal, natural gas, or nuclear fission -- make electricity by generating steam that turns a turbine. That steam then is condensed back to water, and the cycle begins again.
But the condensers that collect the steam are quite inefficient, and improving them could make a big difference in overall power plant efficiency.
Now, a team of researchers at MIT has developed a way of coating these condenser surfaces with a layer of graphene, just one atom thick, and found that this can ...
Chicago, IL, USA (30 May 2015) -- The benefits of adding liver-directed SIR-Spheres Y-90 resin microspheres to a current systemic chemotherapy for the first-line treatment of unresectable metastatic colorectal cancer (mCRC) reported in the SIRFLOX study, were presented at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago. The results of the 530-patient SIRFLOX randomized controlled study, which open new possibilities for combining radiation targeted at liver metastases with first-line systemic treatment of mCRC, were presented by Associate Professor ...
Chicago and Madrid, June 1st 2015: PharmaMar today announced data from a Phase 1b study of the transcriptional inhibitor PM1183 in combination with doxorubicin in second line therapy in patients with small cell lung cancer (SCLC) showing that the treatment induced objective responses in 67% of the patients, including 10% of them where all signs of cancer disappeared (complete responses). Every patient with SCLC denominated primary chemotherapy-sensitive (their chemotherapy-free interval (CTFI) is more than 90 days) responded to treatment, including 18% of complete responses. ...
Chicago and Madrid, June 1st 2015: PharmaMar today announced data from a Phase 2 study in patients with sarcomatoid/biphasic malignant pleural mesothelioma showing that 41.2% (95% CI: 18.4-67.1) of patients treated with the anticancer drug trabectedin in second line were alive and free of progression at 12 weeks. The median progression-free survival (PFS) in these 17 evaluated patients was 8.3 weeks. There were 5 patients who continue receiving trabectedin beyond 12 weeks.
"Mesothelioma patients usually do not respond to second-line treatments so the preliminary data ...
PORTLAND, Ore., June 01, 2015 -- Women who took vitamin D and calcium supplements had the same number of menopausal symptoms as women who did not take the supplements, according to a study published today in Maturitas, the official journal of the European Menopause and Andropause Society.
The study, which involved 34,157 women ages 50-79, is part of the Women's Health Initiative, one of the largest clinical trials ever undertaken to address the most common causes of death, disability and impaired quality of life in menopausal women.
"Our study suggests that women ...
Aging is associated with significant decline in cognitive functions. But does this translate into poorer decision making? Psychologists from the University of Basel and the Max Planck Institute for Human Development report that in simple decision situations, older adults perform just as well as younger adults. However, according to their study published in the academic journal Cognition, aging may affect decision performance in more complex decision situations.
Important decisions in politics and economics are often made by older people: According to Forbes magazine, ...
The NHS could achieve up to twice as much with the resources that the Government plans to spend introducing a full seven day service in the NHS in England, according to new research from The University of Manchester.
Health economists, working with colleagues at the University of York, have used official data to suggest an extra 5,353 deaths each year occur when people are admitted to hospital at the weekend rather than mid-week, but that the £1.43 billion cost of removing this risk would be better spent on other priorities.
Despite a seven day health service ...
